Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMO’s Recalled MoisturePlus Lens Solution Had $106 Mil. In Sales Last Year

This article was originally published in The Gray Sheet

Executive Summary

Advanced Medical Optics is recalling its Complete MoisturePlus contact lens solution after an investigation by the Centers for Disease Control and Prevention found a potential link between the product and a rare eye infection

You may also be interested in...



FDA Is Revising Contact-Lens Guidelines To Protect Against Infections

The agency’s ophthalmic device advisory panel is meeting in May to address FDA’s plans to revise guidance documents describing 510(k) submissions for contact lenses and lens care products. The changes would incorporate lessons learned since the infectious outbreaks linked to multipurpose contact lens solution in the past decade.

Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on the exterior packaging, FDA's Ophthalmic Devices Panel says

Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on the exterior packaging, FDA's Ophthalmic Devices Panel says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024858

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel